European Bioplastics (EUBP) has released its 2025 Bioplastics Market Development Update, presenting an optimistic picture of industry growth. But behind the upbeat messaging lies a stubborn reality: bioplastics remain a very small player, making up just 0.5% of the world’s 431 million tonnes of plastics. Even if global production capacity doubles by 2030—as the report projects—the sector will still occupy only less than 1% of the market.
EUBP frames the increase from 2.31 to 4.69 million tonnes of capacity as evidence of bioplastics’ expanding role in a circular economy. Yet the numbers show that bioplastics, while developing technologically, are far from displacing conventional plastics or materially shifting global plastic production trends. Most growth is occurring from a small base, and the gulf between ambition and impact remains large.
The report highlights rising capacities in PHA, PLA, bioPP and bioPE, with Europe focusing on expanding domestic production. But even here, utilisation rates tell a more complex story: in 2025 the sector operated at just 72% capacity globally. Some polymers run closer to full utilisation, but others sit as low as 28%, suggesting ongoing challenges in market demand, cost competitiveness and infrastructure readiness.
Packaging still dominates bioplastics applications, accounting for 41.3% of production. Automotive and transport are growing, but from small volumes. Despite diversification across industries, the sector is still heavily constrained by economics and policy uncertainty—issues EUBP acknowledges only briefly while calling for more supportive regulation.
While the report celebrates “steady growth,” the broader picture remains clear: bioplastics are not yet making a meaningful dent in conventional plastic production. Without major policy shifts, significant investment, and scalable feedstock solutions, bioplastics’ role in solving the plastics crisis will remain limited. In the short-term, our only hope for solving the plastic crisis depends on recycling in all its messy forms.
The data was compiled with support from the Nova-Institute (Hürth, Germany).